A majority of patients with systemic lupus erythematosus achieve prolonged remission when treated with hydroxychloroquine at ...

Remission was evaluated according to so-called DORIS (Definition of Remission in SLE) criteria. Targets for cardiovascular risk factors were based on standard recommendations, such as blood ...

A cohort study finds that hydroxychloroquine use in cutaneous lupus erythematosus reduces the risk of developing systemic ...